Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan

Leukemia. 2000 Jun;14(6):1156-7. doi: 10.1038/sj.leu.2401790.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Female
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Myelodysplastic Syndromes / drug therapy*
  • Pilot Projects
  • Vitamin K / analogs & derivatives*
  • Vitamin K / therapeutic use
  • Vitamin K 2 / analogs & derivatives

Substances

  • Vitamin K 2
  • Vitamin K
  • menatetrenone